[LABP] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
21-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 42.26%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 0 0 18,000 0 0 0 -
PBT -21,935 -39,276 -38,422 -30,144 -13,467 -6,044 29.39%
Tax 0 -1,285 -196 0 464 1,899 -
NP -21,935 -37,991 -38,226 -30,144 -13,931 -6,044 29.39%
Tax Rate - - - - - - -
Total Cost 21,935 37,991 56,226 30,144 13,931 6,044 29.39%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 0.00 0.00 -212.37 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -3.50 -9.44 -9.50 -7.51 -3.47 -2.62 5.95%
EPS Diluted -3.50 -9.44 -9.50 -7.51 -3.47 -2.62 5.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.